EMA Authorised: Reagila (cariprazine hydrochloride) — Gedeon Richter

View source ↗

Summary

The European Medicines Agency authorised Reagila (cariprazine) for schizophrenia, with Gedeon Richter as the marketing authorisation holder (decision date 08/01…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Reagila (cariprazine)

Snippet

Status: Authorised. Therapeutic area: Schizophrenia. MAH: Gedeon Richter. Decision date: 08/01/2026